weight regain after stopping glp-1 agonists cessation of medication for weight management: systematic review and meta-analysis Patients Who Lose Less Than
Description
Diabetes Care 40 , 10731081 (2017)
To report SUSPECTED ADVERSE REACTIONS, contact Novo Nordisk Inc
Ethics declarations Conflicts of Interest T
Left unchecked, it can cause fatty deposits to build up in artery walls, raising the risk of heart attack, stroke and other cardiovascular disease
